Pulse Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Pulse Biosciences
PLSE Stock  USD 17.61  0.03  0.17%   
Pulse Biosciences financial statements provide useful quarterly and yearly information to potential Pulse Biosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Pulse Biosciences financial statements helps investors assess Pulse Biosciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Pulse Biosciences' valuation are summarized below:
Gross Profit
-550 K
Market Capitalization
992.9 M
Enterprise Value Revenue
64.6261
Revenue
-9 K
Earnings Share
(0.82)
There are over one hundred nineteen available trending fundamental ratios for Pulse Biosciences, which can be analyzed over time and compared to other ratios. Investors should ensure to check out all of Pulse Biosciences' recent performance against the performance from 2010 to 2025 to make sure the company is sustainable down the road.

Pulse Biosciences Total Revenue

(9,832.5)

Check Pulse Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pulse Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 1.6 M, Selling General Administrative of 14.7 M or Research Development of 18.1 M, as well as many indicators such as Price To Sales Ratio of 234, Dividend Yield of 0.0 or PTB Ratio of 16.01. Pulse financial statements analysis is a perfect complement when working with Pulse Biosciences Valuation or Volatility modules.
  
Check out the analysis of Pulse Biosciences Correlation against competitors.
For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.

Pulse Biosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets49.9 M68 M40.2 M
Slightly volatile
Other Current Liabilities2.5 M4.4 M1.9 M
Slightly volatile
Total Current Liabilities4.4 M7.7 M3.3 M
Slightly volatile
Other Liabilities1.2 M1.1 M1.4 M
Slightly volatile
Net Tangible Assets26.1 M34.1 M20.7 M
Slightly volatile
Property Plant And Equipment Net6.1 M10.1 M4.5 M
Slightly volatile
Current Deferred Revenue22.2 K14.4 K23.6 K
Slightly volatile
Accounts Payable1.4 M2.1 M1 M
Slightly volatile
Cash53.6 M51 M22.1 M
Slightly volatile
Non Current Assets Total14.8 M15.9 M13 M
Slightly volatile
Cash And Short Term Investments33.5 M51 M26.1 M
Slightly volatile
Good Will2.2 M2.5 M2.7 M
Slightly volatile
Common Stock Total Equity17.6 K28.8 K16.5 K
Slightly volatile
Common Stock Shares Outstanding58 M55.2 M22.3 M
Slightly volatile
Liabilities And Stockholders Equity49.9 M68 M40.2 M
Slightly volatile
Non Current Liabilities Total12.6 M9.3 M9 M
Slightly volatile
Other Current Assets1.2 M1.1 M812 K
Slightly volatile
Other Stockholder Equity460.3 M438.4 M159.7 M
Slightly volatile
Total Liabilities17 M17 M12.2 M
Slightly volatile
Property Plant And Equipment Gross14.8 M14.1 M5.5 M
Slightly volatile
Total Current Assets35.1 M52.1 M27.2 M
Slightly volatile
Intangible Assets1.6 M1.7 M5.2 M
Slightly volatile
Common Stock47 K49.5 K14.2 M
Very volatile
Property Plant Equipment13.6 M12.9 M4.8 M
Slightly volatile
Capital Surpluse115.4 M224.7 M102.5 M
Slightly volatile
Net Invested Capital35.4 M39.9 M44.2 M
Pretty Stable
Net Working Capital39.8 M44.4 M36.9 M
Pretty Stable
Capital Stock34.5 K63.2 K28.4 K
Slightly volatile
Short and Long Term Debt Total10 M10.5 M12.2 M
Slightly volatile
Capital Lease Obligations10.6 M10.5 M8.1 M
Slightly volatile
Short Term Debt1.4 M1.2 M1.2 M
Slightly volatile
Short and Long Term Debt744.1 K1.1 M554 K
Slightly volatile

Pulse Biosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative14.7 M18.1 M10.4 M
Slightly volatile
Research Development18.1 M32 M13.4 M
Slightly volatile
Total Operating Expenses36.2 M50.1 M26 M
Slightly volatile
Depreciation And Amortization1.1 M1.4 M919.3 K
Slightly volatile
Other Operating Expenses41.9 M50.1 M28.6 M
Slightly volatile
Interest Income124.5 K131.1 K179 K
Pretty Stable
Reconciled Depreciation1.3 M1.4 M1.1 M
Slightly volatile
Selling And Marketing Expenses1 M1.1 M6 M
Pretty Stable

Pulse Biosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation1.1 M1.4 M827.2 K
Slightly volatile
Capital Expenditures103.5 K108.9 K349.5 K
Very volatile
Total Cash From Financing Activities35.7 M18.8 M26.8 M
Slightly volatile
End Period Cash Flow53.6 M51 M23.6 M
Slightly volatile
Change To Liabilities925.5 K1.4 M715.2 K
Slightly volatile
Stock Based Compensation8.9 M8.3 M5.8 M
Slightly volatile
Begin Period Cash Flow73.8 M70.3 M22.2 M
Slightly volatile
Net Borrowings325.6 K366.3 K399.4 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio234154260
Slightly volatile
Days Sales Outstanding12.5614.1315.4071
Slightly volatile
Average Payables118.1 K132.9 K144.9 K
Slightly volatile
Stock Based Compensation To Revenue9.758.539.7921
Slightly volatile
Capex To Depreciation0.110.120.429
Pretty Stable
EV To Sales239179255
Slightly volatile
Inventory Turnover0.270.30.3313
Slightly volatile
Days Of Inventory On Hand8649721.1 K
Slightly volatile
Payables Turnover0.560.591.859
Pretty Stable
Sales General And Administrative To Revenue13.3517.9414.5356
Slightly volatile
Research And Ddevelopement To Revenue19.9826.7921.7925
Slightly volatile
Capex To Revenue0.350.520.3571
Slightly volatile
Cash Per Share1.841.061.9215
Slightly volatile
Days Payables Outstanding443500391
Slightly volatile
Income Quality0.580.70.6295
Slightly volatile
Intangibles To Total Assets0.08640.09090.3183
Slightly volatile
Current Ratio14.547.7720.3242
Slightly volatile
Receivables Turnover18.620.9222.8102
Slightly volatile
Graham Number7.714.916.4744
Very volatile
Capex Per Share0.00280.00290.0279
Pretty Stable
Revenue Per Share0.03930.02370.0445
Slightly volatile
Interest Debt Per Share0.190.20.4383
Pretty Stable
Debt To Assets0.130.140.2178
Pretty Stable
Operating Cycle8779861.1 K
Slightly volatile
Days Of Payables Outstanding443500391
Slightly volatile
Ebt Per Ebit1.181.111.222
Slightly volatile
Long Term Debt To Capitalization0.830.931.0163
Slightly volatile
Total Debt To Capitalization0.150.17090.2417
Pretty Stable
Quick Ratio14.487.7720.2778
Slightly volatile
Net Income Per E B T0.740.910.9261
Very volatile
Cash Ratio10.057.6117.4478
Slightly volatile
Days Of Inventory Outstanding8649721.1 K
Slightly volatile
Days Of Sales Outstanding12.5614.1315.4071
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.191.151.184
Slightly volatile
Fixed Asset Turnover0.110.08030.1152
Slightly volatile
Debt Ratio0.130.140.2178
Pretty Stable
Price Sales Ratio234154260
Slightly volatile
Asset Turnover0.01940.01030.0226
Slightly volatile

Pulse Biosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap16.8 M28.4 M23.8 M
Slightly volatile
Enterprise Value26.4 M25.1 M20 M
Slightly volatile

Pulse Fundamental Market Drivers

Cash And Short Term Investments44.4 M

Pulse Upcoming Events

4th of April 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Pulse Biosciences Financial Statements

Pulse Biosciences stakeholders use historical fundamental indicators, such as Pulse Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Pulse Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pulse Biosciences' assets and liabilities are reflected in the revenues and expenses on Pulse Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pulse Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue14.4 K22.2 K
Total Revenue-10.3 K-9.8 K
Cost Of Revenue1.4 M2 M
Stock Based Compensation To Revenue 8.53  9.75 
Sales General And Administrative To Revenue 17.94  13.35 
Research And Ddevelopement To Revenue 26.79  19.98 
Capex To Revenue 0.52  0.35 
Revenue Per Share 0.02  0.04 
Ebit Per Revenue(95.38)(100.15)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
MSFTMicrosoft
VVisa Class A
CCitigroup
When determining whether Pulse Biosciences is a strong investment it is important to analyze Pulse Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulse Biosciences' future performance. For an informed investment choice regarding Pulse Stock, refer to the following important reports:
How To Invest In Pulse
Details
Is Pulse Stock a good investment?
Details
What is Pulse Biosciences' Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Pulse Biosciences Correlation against competitors.
For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulse Biosciences. If investors know Pulse will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulse Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.82)
Return On Assets
(0.38)
Return On Equity
(0.70)
The market value of Pulse Biosciences is measured differently than its book value, which is the value of Pulse that is recorded on the company's balance sheet. Investors also form their own opinion of Pulse Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pulse Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulse Biosciences' market value can be influenced by many factors that don't directly affect Pulse Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Pulse Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulse Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulse Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY